Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Auger

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Pathogens (Basel, Switzerland)|September 11, 2019
Characterization and Protective Activity of Monoclonal Antibodies Directed against <i>Streptococcus suis</i> Serotype 2 Capsular Polysaccharide Obtained Using a GlycoconjugateGuillaume Goyette-Desjardins, Sonia Lacouture, Jean-Philippe Auger, et al.
Pathogens (Basel, Switzerland)|February 27, 2020
Recognition of Lipoproteins by Toll-like Receptor 2 and DNA by the AIM2 Inflammasome Is Responsible for Production of Interleukin-1β by Virulent Suilysin-negative <i>Streptococcus suis</i> Serotype 2Agustina Lavagna, Jean-Philippe Auger, Stephen E Girardin, et al.
Microorganisms|November 27, 2021
Role of Maturation of Lipoproteins in the Pathogenesis of the Infection Caused by <i>Streptococcus suis</i> Serotype 2Servane Payen, David Roy, Anaïs Boa, et al.
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|April 9, 2015
Role of the capsular polysaccharide as a virulence factor for Streptococcus suis serotype 14David Roy, Jean-Philippe Auger, Mariela Segura, et al.
BMC Veterinary Research|December 12, 2019
Enolase and dipeptidyl peptidase IV protein sub-unit vaccines are not protective against a lethal Streptococcus suis serotype 2 challenge in a mouse model of infectionAudrey Dumesnil, Léa Martelet, Daniel Grenier, et al.
Frontiers in Immunology|June 15, 2018
<i>Streptococcus suis</i> Serotype 2 Infection Impairs Interleukin-12 Production and the MHC-II-Restricted Antigen Presentation Capacity of Dendritic CellsCorinne Letendre, Jean-Philippe Auger, Paul Lemire, et al.
Emerging Infectious Diseases|September 21, 2016
Streptococcus suis Serotype 2 Capsule In VivoJean-Philippe Auger, Nattakan Meekhanon, Masatoshi Okura, et al.
The Journal of Biological Chemistry|June 10, 2018
Structural analysis and immunostimulatory potency of lipoteichoic acids isolated from three <i>Streptococcus suis</i> serotype 2 strainsNicolas Gisch, Jean-Philippe Auger, Simone Thomsen, et al.
Frontiers in Immunology|September 13, 2017
Type I Interferon Induced by <i>Streptococcus suis</i> Serotype 2 is Strain-Dependent and May Be Beneficial for Host SurvivalJean-Philippe Auger, Agustina Santinón, David Roy, et al.
Pathogens (Basel, Switzerland)|January 11, 2018
Limited Interactions between Streptococcus Suis and Haemophilus Parasuis in In Vitro Co-Infection StudiesAnnabelle Mathieu-Denoncourt, Corinne Letendre, Jean-Philippe Auger, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Pathogens (Basel, Switzerland)|September 11, 2019
Characterization and Protective Activity of Monoclonal Antibodies Directed against <i>Streptococcus suis</i> Serotype 2 Capsular Polysaccharide Obtained Using a GlycoconjugateGuillaume Goyette-Desjardins, Sonia Lacouture, Jean-Philippe Auger, et al.
Pathogens (Basel, Switzerland)|February 27, 2020
Recognition of Lipoproteins by Toll-like Receptor 2 and DNA by the AIM2 Inflammasome Is Responsible for Production of Interleukin-1β by Virulent Suilysin-negative <i>Streptococcus suis</i> Serotype 2Agustina Lavagna, Jean-Philippe Auger, Stephen E Girardin, et al.
Microorganisms|November 27, 2021
Role of Maturation of Lipoproteins in the Pathogenesis of the Infection Caused by <i>Streptococcus suis</i> Serotype 2Servane Payen, David Roy, Anaïs Boa, et al.
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|April 9, 2015
Role of the capsular polysaccharide as a virulence factor for Streptococcus suis serotype 14David Roy, Jean-Philippe Auger, Mariela Segura, et al.
BMC Veterinary Research|December 12, 2019
Enolase and dipeptidyl peptidase IV protein sub-unit vaccines are not protective against a lethal Streptococcus suis serotype 2 challenge in a mouse model of infectionAudrey Dumesnil, Léa Martelet, Daniel Grenier, et al.
Frontiers in Immunology|June 15, 2018
<i>Streptococcus suis</i> Serotype 2 Infection Impairs Interleukin-12 Production and the MHC-II-Restricted Antigen Presentation Capacity of Dendritic CellsCorinne Letendre, Jean-Philippe Auger, Paul Lemire, et al.
Emerging Infectious Diseases|September 21, 2016
Streptococcus suis Serotype 2 Capsule In VivoJean-Philippe Auger, Nattakan Meekhanon, Masatoshi Okura, et al.
The Journal of Biological Chemistry|June 10, 2018
Structural analysis and immunostimulatory potency of lipoteichoic acids isolated from three <i>Streptococcus suis</i> serotype 2 strainsNicolas Gisch, Jean-Philippe Auger, Simone Thomsen, et al.
Frontiers in Immunology|September 13, 2017
Type I Interferon Induced by <i>Streptococcus suis</i> Serotype 2 is Strain-Dependent and May Be Beneficial for Host SurvivalJean-Philippe Auger, Agustina Santinón, David Roy, et al.
Pathogens (Basel, Switzerland)|January 11, 2018
Limited Interactions between Streptococcus Suis and Haemophilus Parasuis in In Vitro Co-Infection StudiesAnnabelle Mathieu-Denoncourt, Corinne Letendre, Jean-Philippe Auger, et al.
Pageof 5